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respectively; and Sal02, TR4699 and TR2 having 15, 20 and 23
alleles respectively.
Conclusion: In summary, we have identiﬁed 6 polymorphic
VNTR loci suitable for MLVA analysis of Salmonella Typhi strains.
The ﬁvemost diverse VNTR loci will be selected for theMLVA assay
and will be used to analyse Salmonella Typhi strains from SSA. This
work will assist in rapidly identifying strain relatedness and assist
outbreak detection in typhoid fever outbreaks.
http://dx.doi.org/10.1016/j.ijid.2014.03.715
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Background: Inﬂuenza is a highly contagious viral infection of
the respiratory passages causing fever, headache, severe aching,
cough, and periodically causes epidemics especially in temper-
ate environments. In many African countries, people do not visit
clinics or hospitals with just inﬂuenza infection. Majority of ILI
patients do not seekmedical care and very few of thosewho do, get
tested for inﬂuenza. The many of inﬂuenza cases that are reported
by surveillance programs are from sentinel sites where patients
come in with other medical problems. Clinically, inﬂuenza is not
distinguishable from most other infectious diseases with fever in
the tropics. Malaria is an important infectious disease and is still
thought to be the main cause of febrile episodes. Most fevers are
thought to be malaria. Our investigations sort to establish infor-
mation on incidence of malaria in patients who are positive with
Inﬂuenza infection.
Methods&Materials:This cross-sectionalpilot studyexamined
incidence of malaria among outpatient visits and hospitalizations
associatedwith Inﬂuenza like Illnesses (ILI) andSevereAcuteRespi-
ratory Illness (SARI) during the period February 2011-November
2013 in children, youth and adults attending six health facilities
of; Kawaala health centre III, Kitebi Health centre III, UVRI Clinic,
EntebbeHospital andMbarara Regional referral hospital inUganda.
Nasopharyngeal and oralpharyngeal swabs were collected from
patientsmeeting theWHOcasedeﬁnition for ILI andSARI. Inﬂuenza
viruses were screened for using RT- PCR and the clinical data pre-
senting diagnosis of malaria was collected and analyzed.
Results: Out of the 1020inﬂuenza specimens collected from
cases; 754 (73.9%) patientswere diagnosedwithmalaria; 116 (15%)
of 754 were positive for Inﬂuenza and 638 (84.6%) were negative;
positive for Inﬂuenza A were 71(9.4%) with two subtypes; 56(7.4%)
A(H3) and 15(2.6%) Pandemic A(H1N1) 2009, and 45 (6.0%) were
Inﬂuenza B viruses. Of the 116 positives 108(93.1%) were ILI and
8(6.9%) were SARI patients. Although 107 (92.2%) Children diag-
nosed with Malaria had Inﬂuenza, 9 (7.8%) Youth had Inﬂuenza
whereas there was no Inﬂuenza in Adult.
Conclusion: Our data shows a high incidence of Inﬂuenza in
children diagnosed with malaria.
http://dx.doi.org/10.1016/j.ijid.2014.03.716
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Background: Clostridium difﬁcile infection (CDI) have
increased in frequency and severity over the past decade and
are a leading cause of hospital acquired infections. In Slovakia,
mandatory surveillance of Clostridium difﬁcile infection and
others health care associated infection was established due to
electronically national Epidemiological information systems
(EPIS). But only a few cases of CDI were reported as a healthcare
associated infection in EPIS during last years. Therefore the aim of
this hospital-based survey was to assess incidence, risk factors and
outcome of CDI in University Hospital Trnava, Slovakia in period
2010-2012.
Methods & Materials: We analysed all patients with laboratory
conﬁrmed CDI in University Hospital Trnava during three years
period (RIDA®QUICK Clostridium difﬁcile Toxin A/B immunochro-
matographic rapid assay for the qualitative determination of the
toxins A and B of Clostridium difﬁcile in stool samples, R-Biopharm).
Incidence rate per 10000 hospitalized patientswere calculated and
patients characteristic were recorded from hospital information
systems.
Results: Together 208 hospitalized patients were conﬁrmed
Clostridium difﬁcile toxin in stool samples. Incidence of CDI in
hospitalized patients during three years period 2010, 2011, 2012
increased 24/10 000, 27/10 000, 32/10 000 respectively. Health
care –associated CDI were more often identiﬁed than community-
acquired CDI (73,6% vs. 26,4%). Mean age of infected patients
were 73±16 (range 15-96) and female (60%) were more fre-
quent infected than male. The most affected were Geriatric
Department (29,3%), Department of Infectious Diseases (25%)
and Department of Internal Medicine (24%). Concerning risk fac-
tors, most patients before development CDI received antibiotics -
ciproﬂoxacin, cefuroxime and ampicillin/sulbactam due to respira-
tion or urinary tract infection. Recurrence of CDI was conﬁrmed in
7,7% patients and occurring within 3 months after the ﬁrst episode.
Almost all cases (99%) were treated with metronidazole, others 4
cases with rifaximin (2), vancomycin (1) and ﬁdaxomicínom (1).
Death associated with CDI was observed in two patients.
